🇺🇸 FDA
Patent

US 10335426

N-acetyl mannosammine as a therapeutic agent

granted A61KA61K31/7008A61K31/7012

Quick answer

US patent 10335426 (N-acetyl mannosammine as a therapeutic agent) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/7008, A61K31/7012, A61P, A61P13/12